Jump Financial’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,795
Closed -$7.8M 2037
2025
Q4
$7.8M Buy
76,795
+24,722
+47% +$1.99M 0.1% 269
2025
Q3
$2.85M Buy
+52,073
New +$2.6M 0.03% 594
2024
Q3
Sell
-55,502
Closed -$2.34M 1783
2024
Q2
$2.34M Buy
+55,502
New +$3.05M 0.05% 486
2023
Q4
Sell
-30,448
Closed -$2.08M 1914
2023
Q3
$2.08M Buy
+30,448
New +$2.58M 0.08% 353
2023
Q1
Sell
-7,151
Closed -$354K 1722
2022
Q4
$354K Sell
7,151
-123,818
-95% -$5.06M 0.02% 949
2022
Q3
$4.25M Buy
+130,969
New +$5.4M 0.17% 178
2021
Q1
Sell
-9,970
Closed -$1.32M 1035
2020
Q4
$1.32M Buy
9,970
+1,257
+14% +$152K 0.22% 96
2020
Q3
$889K Buy
+8,713
New +$752K 0.18% 157

Other funds holding EXAS

Jump Financial's EXAS Position: Q1 2026 in Review

Jump Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 76,795 shares — an estimated $7.8M sold.

Jump Financial first reported a position in EXAS in Q3 2020 and held it in 8 quarters. The position peaked at $7.8M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Jump Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 76,795 Exact Sciences shares in Q1 2026, an estimated $7.8M.
  • Jump Financial first reported a position in Exact Sciences in Q3 2020 and held it in 8 quarters.
  • Jump Financial's Exact Sciences position peaked at $7.8M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.